Regenerative Focus Vetrix specializes in veterinary regenerative medicine and autologous cancer immunotherapy, presenting opportunities to upsell regenerative solutions and personalized therapies to veterinary clinics treating injured and oncologic patients.

Equine Expansion The launch of EyeQ Equine Amniotic Eye Drops signals a strategic product expansion into equine care, offering cross-sell potential to clinics serving larger animal patients and equine specialists.

Regenerative Productivity With a tech stack that includes surgical products and bio­sis offerings, there is potential to partner with clinics on adoption of Vetrix BioSIS and VetiVax immunotherapy, leveraging case studies and CI/PI programs.

Digital Reach Presence on Shopify and digital marketing tools indicates readiness for direct-to-clinic sales and online education campaigns, enabling targeted outreach to veterinary surgeons and oncology teams.

Growth Readiness Revenue under one million and small team size suggest agile partnerships, channel programs, and co-marketing opportunities with limited-distribution or exclusive veterinary distributors to scale adoption efficiently.